Recursion Pharmaceuticals
RXRX
#5082
Rank
$1.76 B
Marketcap
$2.82
Share price
3.86%
Change (1 day)
-32.09%
Change (1 year)

EPS for Recursion Pharmaceuticals (RXRX)

EPS in 2026 (TTM): -$0.90

According to Recursion Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$0.90. In 2025 the company made an earnings per share (EPS) of -$1.48 an increase over its 2024 EPS that were of -$1.66.

EPS history for Recursion Pharmaceuticals from 2021 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-$0.90-39.19%
2025-$1.48-10.84%
2024-$1.665.73%
2023-$1.5714.6%
2022-$1.3717.39%
2021-$1.17